Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager

Clarithromycin is a 14-membered-ring , macrolide antibiotic, a derivative of erythromycin, that is commonly used for the treatment of chronic, obstructive upper - and lower respiratory -, skin - and soft tissue -, as well as for gastric (duodenal ulcers caused by H. pylon] infections. During this st...

Full description

Bibliographic Details
Main Author: De Jager, Mari-Alet
Published: North-West University 2009
Online Access:http://hdl.handle.net/10394/898
id ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-898
record_format oai_dc
spelling ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-8982014-04-16T03:55:10ZPolymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de JagerDe Jager, Mari-AletClarithromycin is a 14-membered-ring , macrolide antibiotic, a derivative of erythromycin, that is commonly used for the treatment of chronic, obstructive upper - and lower respiratory -, skin - and soft tissue -, as well as for gastric (duodenal ulcers caused by H. pylon] infections. During this study, polymorphic and pseudopolymorphic forms were evaluated, identified and characterised, using normal spectral and thermal methods, such as x-ray powder diffractometry, infrared spectroscopy, differential scanning calorimetry, thermogravimetrical analysis and thermal microscopy. Literature described Form 0, a solvate; Form I, a metastable polymorph; Form II, the thermodynamically more stable polymorph; Form Ill, a solvate (from acetonitrile) and Form IV, an amorph. Various solvents were used for slow recrystallisation of clarithromycin. The thermodynamically more stable Form II was prepared from acetone, methanol, benzene, dimethylformamide and tetrahydrofuran. Recrystallisations from acetonitrile produced Form II, and not Form Ill as reported in the literature. Two new forms, i.e. an ethyl acetate (Form V) and a chloroform solvate (Form VI) were prepared. Recrystallisation from both ethanol and iso-propanol produced Forms 0 and II. Although Form 0 desolvated prior to analysis, thus no longer contained the recrystallisation solvent, these crystals retained the structure of the solvated Form 0. Form 0 was recrystallised from n-propanol, n-butanol, dioxane and dichloromethane. Forms 0, 1, Ill, V and VI all transformed into the thermodynamically more stable Form II, after storage at room conditions. The dissolution results, relating to chloroform recrystallisation, showed that desolvation can improve the dissolution rate, since the chloroform solvate had a poor dissolution performance (61% after 30 minutes), whilst the desolvated form was almost completely dissolved within 30 minutes (96%), in the 0.1 M sodium acetate buffer.Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.North-West University2009-02-18T06:30:35Z2009-02-18T06:30:35Z2005Thesishttp://hdl.handle.net/10394/898
collection NDLTD
sources NDLTD
description Clarithromycin is a 14-membered-ring , macrolide antibiotic, a derivative of erythromycin, that is commonly used for the treatment of chronic, obstructive upper - and lower respiratory -, skin - and soft tissue -, as well as for gastric (duodenal ulcers caused by H. pylon] infections. During this study, polymorphic and pseudopolymorphic forms were evaluated, identified and characterised, using normal spectral and thermal methods, such as x-ray powder diffractometry, infrared spectroscopy, differential scanning calorimetry, thermogravimetrical analysis and thermal microscopy. Literature described Form 0, a solvate; Form I, a metastable polymorph; Form II, the thermodynamically more stable polymorph; Form Ill, a solvate (from acetonitrile) and Form IV, an amorph. Various solvents were used for slow recrystallisation of clarithromycin. The thermodynamically more stable Form II was prepared from acetone, methanol, benzene, dimethylformamide and tetrahydrofuran. Recrystallisations from acetonitrile produced Form II, and not Form Ill as reported in the literature. Two new forms, i.e. an ethyl acetate (Form V) and a chloroform solvate (Form VI) were prepared. Recrystallisation from both ethanol and iso-propanol produced Forms 0 and II. Although Form 0 desolvated prior to analysis, thus no longer contained the recrystallisation solvent, these crystals retained the structure of the solvated Form 0. Form 0 was recrystallised from n-propanol, n-butanol, dioxane and dichloromethane. Forms 0, 1, Ill, V and VI all transformed into the thermodynamically more stable Form II, after storage at room conditions. The dissolution results, relating to chloroform recrystallisation, showed that desolvation can improve the dissolution rate, since the chloroform solvate had a poor dissolution performance (61% after 30 minutes), whilst the desolvated form was almost completely dissolved within 30 minutes (96%), in the 0.1 M sodium acetate buffer. === Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.
author De Jager, Mari-Alet
spellingShingle De Jager, Mari-Alet
Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager
author_facet De Jager, Mari-Alet
author_sort De Jager, Mari-Alet
title Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager
title_short Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager
title_full Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager
title_fullStr Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager
title_full_unstemmed Polymorphism and pseudopolymorphism of clarithromycin / Mari-Alet de Jager
title_sort polymorphism and pseudopolymorphism of clarithromycin / mari-alet de jager
publisher North-West University
publishDate 2009
url http://hdl.handle.net/10394/898
work_keys_str_mv AT dejagermarialet polymorphismandpseudopolymorphismofclarithromycinmarialetdejager
_version_ 1716664709333123072